ArticleJournal of experimental & clinical cancer research : CR2025

DNA damaging agents boost the transcription of endothelin A receptor in high-grade serous ovarian cancer.

Celia Roman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.